Colace Capsule
Pricing Report NDC 67618-101-52

Current NADAC: $0.30489 per EA · Effective Aug 19, 2026 · Est. package price $76.22 (250 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Colace (NDC 67618-101-52) is $0.30489 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human over the counter drug provided by Atlantis Consumer Healthcare, Inc., this medication is distributed in a 250 CAPSULE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.30489
Per EA

Effective Date
Aug 19, 2026
Billable Units
250 EA
Estimated Package Price
$76.22
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
250 CAPSULE in 1 BOTTLE, PLASTIC
Generic Benchmark
The generic equivalent rate is $0.02773 (Effective: Aug 19, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.26310 to $0.30657 per EA. Over this 12 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2631 - $0.3066
Market Volatility
16.52% Variance
Latest Trend
0.52%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $0.30489 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $0.30489 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $0.30489 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $0.30489 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $0.30489 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $0.30648 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $0.30648 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $0.30648 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $0.30648 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $0.30648 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 17, 2026 $0.30485 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 17, 2026 $0.30485 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026